Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Enhancing HCPs’ Preparedness: Maternal Immunization Knowledge Updates
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Real-World Clinical Outcomes Among Adult and Adolescent Patients with Severe Alopecia Areata Receiving Ritlecitinib in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Education on the Appropriate Diagnosis and Treatment of Overactive Bladder or Neurogenic Bladder
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Internal Medicine Japan
    Interventional Research Studies with Elranatamab
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Research in Ulcerative Colitis (UC) 2024
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Brazil, India, Mexico, Saudi Arabia, Taiwan, Turkey
    Advances in the Management of Ulcerative Colitis (UC)
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology All
    Research in Ulcerative Colitis (UC) 2024
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Switzerland, United Kingdom
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
    BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Oncology Japan
    Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
    Release Date:
    Partner: Sumitomo Pharma
    Review Process: Pfizer Internal
    Education Oncology USA